<DOC>
	<DOCNO>NCT02142920</DOCNO>
	<brief_summary>The purpose study characterize PF-05212384 metabolized body follow single intravenous dose radioactively label drug ( [ 14C ] -PF-05212384 ) .</brief_summary>
	<brief_title>Investigation Of The Metabolism , And Excretion Of 14c-PF-05212384 In Healthy Male Volunteers</brief_title>
	<detailed_description />
	<criteria>Healthy male subject age 30 65 year vasectomise &gt; 40 desire father child near future ( 12 month ) , inclusive ( Healthy define clinically relevant abnormality identify detailed medical history , full physical examination , include blood pressure pulse rate measurement , 12 lead ECG clinical laboratory test ) . Body Mass Index ( BMI ) 17.5 35 kg/m2 ; total body weight &gt; 50 kg ( 110 lb ) . Evidence personally sign date informed consent document indicate subject inform pertinent aspect study . Subjects willing able comply schedule visit , treatment plan , laboratory test , study procedure . Subjects agree use adequate method contraception Evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic , allergic disease ( include drug allergy , exclude untreated , asymptomatic , seasonal allergy time dose ) . A positive urine drug screen history drug alcohol abuse past 2 year .</criteria>
	<gender>Male</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Healthy Volunteers</keyword>
</DOC>